Drug intelligence / Profile preview

sarcosine^1-isoleucine^8-angiotensin II

Development stage
Preclinical
Lead developer
Trevena
Modality
Peptides, Small Molecules
Administration
Inhalation, Intravenous
01

Overview

**sarcosine^1-isoleucine^8-angiotensin II** is a synthetic peptide analogue of angiotensin II in which the first amino acid (aspartic acid) is replaced by sarcosine and the eighth amino acid (phenylalanine) is replaced by isoleucine. It acts as an agonist at the angiotensin II type 1 receptor (AT1R), with some selectivity for β-arrestin signaling pathways. This analogue has been studied for its hemodynamic effects in patients with essential hypertension and inhalation injury, where it can cause transient increases in blood pressure primarily through increased total peripheral resistance[1][6][8]. It has also been used as a research tool to study angiotensin receptor function and localization[2]. The compound is produced synthetically and does not have established therapeutic use or brand names.

Other names
[サル1,イレ8]-アンジオテンシンII
02

Targets

AGTR1 (Angiotensin II Type-1 receptor)

Beyond the preview

Go deeper on sarcosine^1-isoleucine^8-angiotensin II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sarcosine^1-isoleucine^8-angiotensin II.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call